SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-330656
Filing Date
2021-11-16
Accepted
2021-11-16 06:58:57
Documents
12
Period of Report
2021-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d250299d8k.htm   iXBRL 8-K 24450
  Complete submission text file 0001193125-21-330656.txt   150773

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cdak-20211115.xsd EX-101.SCH 2895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20211115_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20211115_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d250299d8k_htm.xml XML 3481
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39615 | Film No.: 211414088
SIC: 2836 Biological Products, (No Diagnostic Substances)